Researchers have identified the genetic risk factors that contribute to prostate cancer in a diverse group of African men.

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was ...

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

NOBODY WANTS TO find out they have prostate cancer. Yet the earlier it's detected, the better. The cancer is very treatable ...

Pfizer’s Talzenna-Xtandi combination has marked a major step forward in treating advanced prostate cancer, improving patient ...

A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical ...

Under the new grant, Agarwal’s lab will work to not only confirm they have identified the correct compounds but to translate ...

Prostate cancer is the most common cancer among men in Sweden, with about 10,000 new cases diagnosed annually. Despite ...

Former Portsmouth goalkeeper Alan Knight has revealed he has advanced prostate cancer. The 61-year spent 22 years at Fratton Park, making 801 appearances between 1978 and 2000 – the record for a ...

The following is a summary of “Characteristics of lymphoedema, in particular midline lymphoedema, after treatment for ...

Jacob E. Berchuck, MD, discussed research behind using a blood-based liquid biopsy in prostate cancer and findings presented ...